Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease? Reply
Rheumatology (Oxford)
.
2019 Jul 1;58(7):1312-1313.
doi: 10.1093/rheumatology/kez074.
Authors
Céline Anquetil
1
2
,
Eric Hachulla
3
,
François Machuron
4
,
Xavier Mariette
5
,
Pierre-Yves Hatron
3
Affiliations
1
Department of Internal Medicine and Clinical Immunology, Sorbonne Université, Pitié-Salpêtrière University Hospital, Paris, France.
2
Centre of Research in Myology, Association Institut de Myologie, UMRS974, Institut National de la Santé et de la Recherche Médicale, Paris, France.
3
Department of Internal Medicine, Claude Huriez Hospital, Univ. Lille, Lille cedex, France.
4
Department of Biostatistics, Univ. Lille, CHU Lille, EA 2694 - Santé Publique : Épidémiologie et Qualité des Soins, Lille, France.
5
Department of Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Sud, Le Kremlin-Bicêtre, France.
PMID:
30859229
DOI:
10.1093/rheumatology/kez074
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Prognosis
Sjogren's Syndrome*